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An increasing number of reports reveal the safety and efficacy of catheter ablation for atrial fibrillation therapy even
in patients with a history of prosthetic heart valve. This case report presents a 60 year old female patient who had a
prosthetic mitral paravalvular leak as a complication of radiofrequency ablation. Surgery revealed a 15 mm hole and
three broken knots in the posterolateral mitral annulus. This report demonstrates radiofrequency ablation for atrial
fibrillation in patients with prosthetic mitral valve may cause a paravalvular leak likely as a result of thermal injury.
Moreover, patient can be asymptomatic at first. The clinician should keep in mind such complication and the
patient should be evaluated in terms of paravalvular leakage.
Keywords: Paravalvular leak, Percutaneous catheter ablation, Prosthetic heart valveBackground
Since its first description in 1982 [1], radio frequency
catheter ablation (RFA) has evolved to its present role as
first-line therapy for most supraventricular arrhythmias
[2-6]. The growing acceptance of this procedure has
been brought about by an increasing number of reports
revealing the safety and efficacy of catheter ablation for
atrial fibrillation (AF) therapy. Reported complications
of RFA include stroke, pericardial tamponade, valvular
injury, pulmonary embolism, atrio-esophageal fistula and
significant pulmonary vein (PV) stenosis [4-6]. We re-
port the case of a patient with a history of mechanical
mitral valve replacement (MVR) who had a paravalvular
leak as a complication of RFA for AF therapy. This case
is presented in order to draw attention to this rare pres-
entation which has never been previously reported in
the medical literature.Case presentation
A sixty-year-old woman with the posterolateral pros-
thetic paravalvular leak (PVL) was referred to our clinic
for surgical repair. She had a history of closed mitral* Correspondence: gurbuzorcun@gmail.com
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unless otherwise stated.commissurotomy 47 years ago, a prosthetic mitral valve
replacement (MVR) in 1975 and a redo MVR in 2005
due valve dysfunction by pannus formation. Moreover,
1 years ago, she had undergone a pulmonary vein isola-
tion (PVI), left atrium and mitral isthmus roof lines abla-
tions for symptomatic persistent AF in another hospital,
using CARTO mapping system (Biosense, Diamond Bar,
CA, USA) and an irrigation ablation catheter (Biosense,
ThermoCool? SF Catheter, USA). Furthermore, RFA was
delivered at pulmonary veins for up to 30 W and at both
lines up to 35 W with a temperature limitation of 50?C.
Despite successful conversion to sinus rhythm she devel-
oped progressive cardiac failure in months. Third month
later, after the percutaneous ablation, she was classified
as decompensating heart failure in New York Heart Asso-
ciation (NYHA) stage four. Transthoracic echocardiog-
raphy revealed a moderate PVL with an ejection fraction
of 60%. Transesophageal echocardiography (TEE) demon-
strated moderate to severe posterolateral prosthetic PVL
(Figure 1). She was referred for surgery as she refused per-
cutaneous closure of PVL. This patient was under echo-
cardiography follow-up every three months, which were
not revealed any PVL or pulmonary hypertension before
the procedure, but three months after the RFA. After
hospitalization, she underwent a coronary angiography,
which revealed no obstructive lesions in coronary arteries.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Transesophageal echocardiography illustrating paravalvular mitral regurgitation. Arrow indicates paravalvular leakage.
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separated by sharp dissection, then cardiopulmonary by-
pass was initiated by aortic and bicaval venous cannula-
tion. Systemic temperature was actively cooled down to
32?C. Following aortic cross-clamping, myocardial protec-
tion was achieved with antegrade and retrograde cold
blood cardioplegia. The left atrium was reached by trans-
septal approach. A 15 mm defect was detected between
mechanical valve and posterolateral mitral annulus where
knot of 3 sutures was found to be broken (Figure 2). The
defect was successfully repaired using separated 2-0 pled-
geted sutures (Figure 3). İmmediately before declampingFigure 2 Perioperative image of paravalvular leak area. Arrow indicatehot shot solution was administered. After declamping the
heart was in nodal rhythm, therefore 5 mcg/kg/min dopa-
mine infusion and VVI pacing via 2 epicardial pacing leads
was initiated. Cardiopulmonary bypass ended 50 minutes
after its initiation. İntraoperative control TEE did not re-
veal any PVL and patient was transferred to the intensive
care unit (ICU). She was extubated within 12 hours and
dopamine infusion was stopped. On the second postoper-
ative day, normal sinus rhythm returned and she was
transferred out of the ICU. On the fourth postoperative
day atrial fibrillation occurred which was converted into
sinus rhythm by amiodarone. The patient was successfullys paravalvular leakage area.
Figure 3 Periopertive image of repaired paravalvular leak area. Arrow indicates repaired paravalvular leakage.
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and completed the 1-year follow-up without complications.
Discussion
Atrial fibrillation is the most common cardiac rhythm dis-
turbances, with a prevalence estimated at 0.5% of the popu-
lation [7]. It frequently arises from an abnormal focus near
the junction of the pulmonary veins and the left atrium.
RFA is a widely used technique as a first-line therapy
for a variety of supraventricular arrhythmias with a low
incidence of complication. Studies generally report
short-term recurrence rates up to 30%, requiring repeat
ablations. Moreover, if early recurrence does not occur
longer-term recurrence rates are reported lower, in the
range of 1-2% per year [8,9]. American Heart Associ-
ation (AHA) suggests catheter ablation in patient with
symptomatic paroxysmal AF or selected patients with
symptomatic persistent AF [10].
Serious complications, including cardiac tamponade,
pulmonary embolism, inferior myocardial infarction,
significant PV stenosis or PV thrombosis, valvular in-
jury, atrio-esophageal fistula and stroke are likely in the
1% ? 5% range.
Our report reveals PVL as a complication of this pro-
cedure in a patient with recent prosthetic mitral valve
replacement. PVL is a well-known complication of pros-
thetic valve implantation, with an estimated incidence of
3% to 6% [11]. PVL can be asymptomatic or can have
significant clinical consequence, such as congestive heart
failure, hemolytic anemia, and infective endocarditis.
Clinical success rates of percutaneous PVL repair ap-
proach 80% to 90% in selected patients [11].
Recent reports revealed favorable outcomes of RFA for
atrial fibrillation therapy in patients with previous MVR.
Moreover, PVL has never been previously reported after
RFA [12,13].Our report shows that during the RFA of left atrium, su-
ture knots can be damaged by catheter induced thermal
injury and PVL might develop. Interestingly, this compli-
cation has not been noticed immediately after treatment,
but just after the development of heart failure.
Conclusion
Radiofrequency ablation for atrial fibrillation in patients
with prosthetic mitral heart valve may cause a paravalvular
leak which can be asymptomatic at first. The clinician
should keep in mind such complication and the patient
should be evaluated in terms of paravalvular leakage.
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